These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 22935043)

  • 1. Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero.
    Rø TB; Ludvigsen HV; Carlsen SM; Vanky E
    Scand J Clin Lab Invest; 2012 Nov; 72(7):570-5. PubMed ID: 22935043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin's effect on first-year weight gain: a follow-up study.
    Carlsen SM; Martinussen MP; Vanky E
    Pediatrics; 2012 Nov; 130(5):e1222-6. PubMed ID: 23071212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast size increment during pregnancy and breastfeeding in mothers with polycystic ovary syndrome: a follow-up study of a randomised controlled trial on metformin versus placebo.
    Vanky E; Nordskar JJ; Leithe H; Hjorth-Hansen AK; Martinussen M; Carlsen SM
    BJOG; 2012 Oct; 119(11):1403-9. PubMed ID: 22827167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].
    Liu ZA; Xue YM; Chen LX; Cai Q; Chen H; Zhang J; Cui QH; Ge J; Yuan T
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):586-90. PubMed ID: 15498183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Aessopos A; Paterakis T; Katsikis I; Panidis D
    Metabolism; 2007 Jan; 56(1):129-34. PubMed ID: 17161235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
    Chou KH; von Eye Corleta H; Capp E; Spritzer PM
    Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
    Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF
    Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
    Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
    Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.
    Glueck CJ; Goldenberg N; Pranikoff J; Loftspring M; Sieve L; Wang P
    Hum Reprod; 2004 Jun; 19(6):1323-30. PubMed ID: 15117896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study.
    Trolle B; Lauszus FF; Frystyk J; Flyvbjerg A
    Fertil Steril; 2010 Nov; 94(6):2234-8. PubMed ID: 20189560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of prenatal exposure to metformin on the health of children based on follow-up studies of randomized controlled trials: a systematic review and meta-analysis.
    Xu Q; Xie Q
    Arch Gynecol Obstet; 2019 May; 299(5):1295-1303. PubMed ID: 30953188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study.
    Fougner KJ; Vanky E; Carlsen SM
    Scand J Clin Lab Invest; 2008; 68(8):771-6. PubMed ID: 18651320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition].
    Le Donne M; Alibrandi A; Giarrusso R; Lo Monaco I; Muraca U
    Minerva Ginecol; 2012 Feb; 64(1):23-9. PubMed ID: 22334228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
    Kilicdag EB; Bagis T; Zeyneloglu HB; Tarim E; Aslan E; Haydardedeoglu B; Erkanli S
    Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5-10 year follow-up of the PregMet randomised controlled trial.
    Hanem LGE; Salvesen Ø; Juliusson PB; Carlsen SM; Nossum MCF; Vaage MØ; Ødegård R; Vanky E
    Lancet Child Adolesc Health; 2019 Mar; 3(3):166-174. PubMed ID: 30704873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
    Song J; Shen H; Li J; Huang Z; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome.
    Glueck CJ; Bornovali S; Pranikoff J; Goldenberg N; Dharashivkar S; Wang P
    Diabet Med; 2004 Aug; 21(8):829-36. PubMed ID: 15270785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.